HUTCHMED (China) HCM
NASDAQ HCM
$14.45 +0.30 (+2.12%)
As of: Sep 30, 2026 · 9:37 AM EDT

HUTCHMED (China) (HCM) EV to EBITDA (2018)

Updated

HUTCHMED (China)'s EV to EBITDA was 85.03 in the year ended Dec 31, 2023.

Analysis

HUTCHMED (China) (HCM) EV to EBITDA (2018) Analysis & Trends

  • The figure for the year ended Dec 31, 2023 marks the lowest annual EV to EBITDA since the year ended Dec 31, 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 HUTCHMED (China) 2.47 Bn 2.48 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 78.88
API Access

HUTCHMED (China) EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=HCM&period=max&api_key=YOUR_API_KEY